BioLine RX (Israel) Today
| BLRX Stock | ILS 16.50 0.20 1.20% |
Performance0 of 100
| Odds Of DistressLess than 14
|
BioLine RX is trading at 16.50 as of the 23rd of April 2024, a -1.2 percent decrease since the beginning of the trading day. The stock's open price was 16.7. BioLine RX has less than a 14 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for BioLine RX are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of June 2023 and ending today, the 23rd of April 2024. Click here to learn more.
BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology. BioLineRx Ltd. was founded in 2003 and is based in Modiin, Israel. BIOLINE RX operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 922.87 M outstanding shares. More on BioLine RX
Moving together with BioLine Stock
| 0.82 | BOLT | BioLight Life Sciences | PairCorr |
Moving against BioLine Stock
| 0.81 | PRTC | Priortech | PairCorr |
| 0.72 | PSTI | Pluristem | PairCorr |
| 0.51 | GPGB | GP Global Power | PairCorr |
| 0.44 | AQUA | Aquarius Engines | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioLine Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioLine RX's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioLine RX or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Kinneret Savitsky |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
BioLine RX (BLRX) is traded on Tel Aviv Stock Exchange in Israel and employs 38 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 135.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioLine RX's market, we take the total number of its shares issued and multiply it by BioLine RX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioLine RX operates under Biotechnology sector and is part of Health Care industry. The entity has 922.87 M outstanding shares.
BioLine RX has accumulated about 40.61 M in cash with (23.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check BioLine RX Probability Of Bankruptcy
Ownership AllocationBioLine RX retains a total of 922.87 Million outstanding shares. Almost 100.0 percent of BioLine RX outstanding shares are held by general public with 0.25 (percent) owned by insiders and only 0.1 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check BioLine Ownership Details
BioLine Stock Price Odds Analysis
What are BioLine RX's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of BioLine RX jumping above the current price in 90 days from now is about 99.0%. The BioLine RX probability density function shows the probability of BioLine RX stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 3.17 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioLine RX will likely underperform. Additionally, bioLine RX has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of BioLine RX to move above the current price in 90 days from now is about 99.0 (This BioLine RX probability density function shows the probability of BioLine Stock to fall within a particular range of prices over 90 days) .
BioLine RX Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BioLine RX market risk premium is the additional return an investor will receive from holding BioLine RX long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioLine RX. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BioLine RX's alpha and beta are two of the key measurements used to evaluate BioLine RX's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.41 | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.34 | |||
| Risk Adjusted Performance | (0.15) |
BioLine Stock Against Markets
Picking the right benchmark for BioLine RX stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioLine RX stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioLine RX is critical whether you are bullish or bearish towards BioLine RX at a given time. Please also check how BioLine RX's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioLine RX without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
BioLine RX Corporate Directors
BioLine RX corporate directors refer to members of a BioLine RX board of directors. The board of directors generally takes responsibility for the BioLine RX's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BioLine RX's board members must vote for the resolution. The BioLine RX board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Avraham Molcho | External Director | Profile | |
| Mali Zeevi | Finance Director | Profile | |
| Michael Anghel | Director | Profile | |
| Raphael Hofstein | Director | Profile |
How to buy BioLine Stock?
Before investing in BioLine RX, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BioLine RX. To buy BioLine RX stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of BioLine RX. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase BioLine RX stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located BioLine RX stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased BioLine RX stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as BioLine RX, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in BioLine RX?
The danger of trading BioLine RX is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BioLine RX is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BioLine RX. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BioLine RX is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLine RX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for BioLine Stock analysis
When running BioLine RX's price analysis, check to measure BioLine RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLine RX is operating at the current time. Most of BioLine RX's value examination focuses on studying past and present price action to predict the probability of BioLine RX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLine RX's price. Additionally, you may evaluate how the addition of BioLine RX to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |